Lv1
48 积分 2024-01-29 加入
Publisher Correction: Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial
2天前
求助中
Publisher Correction: Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial
7天前
已完结
Progress and unmet needs in understanding fundamental mechanisms of autoimmunity
20天前
已完结
Ongoing Immunoglobulin Class Switch DNA Recombination in Lupus B Cells: Analysis of Switch Regulatory Regions
1个月前
已完结
Transferrin Receptor Targeting Chimeras (TransTACs) for Membrane Protein Degradation
1个月前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
5个月前
已完结
The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance
6个月前
已完结
Sequential T-Cell Engagement for Myeloma (“STEM”) Trial: A Phase 2 Study of Cevostamab Consolidation Following BCMA CAR T Cell Therapy
7个月前
已关闭
CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up
8个月前
已完结
Analysis of CAR-Mediated Tonic Signaling
9个月前
已完结
皖公网安备34019202002308
